<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Kenny | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/goalslime35/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/goalslime35/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Kenny.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">eb50faeafd1839ce714ead6603ac83ae</guid>
				<title>Kenny posted an update: st of a patient in conventional therapy. This provided [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42970/</link>
				<pubDate>Sun, 09 Feb 2025 12:12:08 -0800</pubDate>

									<content:encoded><![CDATA[<p>st of a patient in conventional therapy. This provided updated knowledge on the direct medical costs, from the provision of a rheumatic care center service, to support epidemiologic or pharmacovigilance models.The use of autologous orthobiologics is an emerging area of interest in veterinary medicine. In this retrospective study, we reviewed the&hellip;<span class="activity-read-more" id="activity-read-more-42970"><a href="http://www.nationalboardinstitute.com/activity/p/42970/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b88a49d797eeeef4edd885d66a1a80d3</guid>
				<title>Kenny posted an update: try ion suppression or enhancement caused by column bleed [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42081/</link>
				<pubDate>Sat, 08 Feb 2025 12:06:29 -0800</pubDate>

									<content:encoded><![CDATA[<p>try ion suppression or enhancement caused by column bleed from the hybrid particle-based columns should allow for accurate quantitative mass spectrometric detection combined with mixed-mode reversed-phase/weak anion-exchange chromatography.</p>
<p> Semiautomatic fractional limb volume (FLV) models have recently produced promising results for fetal&hellip;<span class="activity-read-more" id="activity-read-more-42081"><a href="http://www.nationalboardinstitute.com/activity/p/42081/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c7d6b13bebfcc4657031118063d2df67</guid>
				<title>Kenny posted an update: Sumerlaeota is a mysterious, putative phylum-level lineage [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41293/</link>
				<pubDate>Fri, 07 Feb 2025 12:30:06 -0800</pubDate>

									<content:encoded><![CDATA[<p>Sumerlaeota is a mysterious, putative phylum-level lineage distributed globally but rarely reported. As such, their physiology, ecology, and evolutionary history remain unknown. The 16S rRNA gene survey reveals that Sumerlaeota is frequently detected in diverse environments globally, especially cold arid desert soils and deep-sea basin surface&hellip;<span class="activity-read-more" id="activity-read-more-41293"><a href="http://www.nationalboardinstitute.com/activity/p/41293/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ad9c430c170597f076f30f3857d59ac0</guid>
				<title>Kenny posted an update: s affecting this vulnerable population.The aim of this [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40467/</link>
				<pubDate>Thu, 06 Feb 2025 16:35:30 -0800</pubDate>

									<content:encoded><![CDATA[<p>s affecting this vulnerable population.The aim of this qualitative study was to explore and describe South African registered psychologists&#8217; account of their patients&#8217; myths regarding hypnotherapy. A social constructivist approach was employed to explore the descriptions of eight psychologists. This article converges on myths of participants&#8217;&hellip;<span class="activity-read-more" id="activity-read-more-40467"><a href="http://www.nationalboardinstitute.com/activity/p/40467/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4129f6e47b492df32d9cee219f0645a8</guid>
				<title>Kenny posted an update: Particularly, LaNAS achieves 99.0% accuracy on CIFAR-10 and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39376/</link>
				<pubDate>Wed, 05 Feb 2025 12:53:52 -0800</pubDate>

									<content:encoded><![CDATA[<p>Particularly, LaNAS achieves 99.0% accuracy on CIFAR-10 and 80.8% top1 accuracy at 600 MFLOPS on ImageNet in only 800 samples, significantly outperforming AmoebaNet with 33x fewer samples. Our code is publicly available at https//github.com/facebookresearch/LaMCTS.Evidence for antithrombotic treatment following lower extremity revascularization&hellip;<span class="activity-read-more" id="activity-read-more-39376"><a href="http://www.nationalboardinstitute.com/activity/p/39376/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">609ebecb4bdcf97fc9df89dc83916c11</guid>
				<title>Kenny posted an update: With an improvement in the survival rate of cancer patients, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38637/</link>
				<pubDate>Tue, 04 Feb 2025 12:11:42 -0800</pubDate>

									<content:encoded><![CDATA[<p>With an improvement in the survival rate of cancer patients, chemotherapy-induced premature ovarian insufficiency (POI) is increasingly affecting the quality of life of female patients. Currently, there are many relevant studies using mice as an animal model. However, a large coefficient of variation for weight in mice is not appropriate for&hellip;<span class="activity-read-more" id="activity-read-more-38637"><a href="http://www.nationalboardinstitute.com/activity/p/38637/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">37be5184846e519ed639ad2ed5d883df</guid>
				<title>Kenny posted an update: Background Autophagy plays a vital role in cancer [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37807/</link>
				<pubDate>Mon, 03 Feb 2025 12:25:21 -0800</pubDate>

									<content:encoded><![CDATA[<p>Background Autophagy plays a vital role in cancer initiation, malignant progression, and resistance to treatment. However, autophagy-related genes (ARGs) have rarely been analyzed in gastric cancer (GC). The purpose of this study was to analyze ARGs in GC using bioinformatic analysis and to identify new biomarkers for predicting the overall&hellip;<span class="activity-read-more" id="activity-read-more-37807"><a href="http://www.nationalboardinstitute.com/activity/p/37807/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7ef84e6e9565905bddd6c13fc19822b2</guid>
				<title>Kenny posted an update: Chimeric antigen receptor T (CAR-T) cell therapies have [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36879/</link>
				<pubDate>Sun, 02 Feb 2025 12:21:40 -0800</pubDate>

									<content:encoded><![CDATA[<p>Chimeric antigen receptor T (CAR-T) cell therapies have demonstrated high response rate and durable disease control for the treatment of B cell malignancies. However, in the case of solid tumors, CAR-T cells have shown limited efficacy, which is partially attributed to intrinsic defects in CAR signaling. Here, we construct a double-chain chimeric&hellip;<span class="activity-read-more" id="activity-read-more-36879"><a href="http://www.nationalboardinstitute.com/activity/p/36879/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d5fbdc9d49944fc8343024ba968ebb46</guid>
				<title>Kenny posted an update: Today, antivirulence compounds that attenuate bacterial [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35964/</link>
				<pubDate>Sat, 01 Feb 2025 12:01:49 -0800</pubDate>

									<content:encoded><![CDATA[<p>Today, antivirulence compounds that attenuate bacterial pathogenicity and have no interference with bacterial viability or growth are introduced as the next generation of antibacterial agents. However, the development of such compounds that can be used by humans is restricted by various factors, including the need for extensive economic&hellip;<span class="activity-read-more" id="activity-read-more-35964"><a href="http://www.nationalboardinstitute.com/activity/p/35964/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f402f75f3ecc25fda167611ace8f4fe7</guid>
				<title>Kenny posted an update: New flavonoid glycoside, kaempferol 3-O-α-[(6-P-coumaroyl [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35022/</link>
				<pubDate>Fri, 31 Jan 2025 12:37:13 -0800</pubDate>

									<content:encoded><![CDATA[<p>New flavonoid glycoside, kaempferol 3-O-α-[(6-P-coumaroyl galactopyranosyl-O-β-(→4)-O-α-rhamnopyranosyl-(1→4)]-O-α-rhamnopyranoside 1, in addition to five known flavonoid glycosides (2-6) kaempferol 3-O-[α-rhamnopyranosyl-(1→4)-O-α-rhamnopyranosyl-(1→6)-O]-β-galactopyranoside (kaempferol 3-O-β-isorhamninoside) 2, quercetin 3-O-[(2,3,4-tri&hellip;<span class="activity-read-more" id="activity-read-more-35022"><a href="http://www.nationalboardinstitute.com/activity/p/35022/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">94f50bdfea5fae18370004dc1360772c</guid>
				<title>Kenny posted an update: Two measures pertained to patient education and five to [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34208/</link>
				<pubDate>Thu, 30 Jan 2025 12:07:18 -0800</pubDate>

									<content:encoded><![CDATA[<p>Two measures pertained to patient education and five to diagnosis, including discussing treatment options with risk and benefits and using the most recent version of the Chicago Classification to define achalasia phenotypes, respectively. Other indicators pertained to treatment options, such as the use of botulinum toxin for those not considered&hellip;<span class="activity-read-more" id="activity-read-more-34208"><a href="http://www.nationalboardinstitute.com/activity/p/34208/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">acc73250eecedb777d8fafe4d3a2f105</guid>
				<title>Kenny posted an update: spital postoperative care beyond 30 days.Medication-related [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28460/</link>
				<pubDate>Tue, 28 Jan 2025 11:23:03 -0800</pubDate>

									<content:encoded><![CDATA[<p>spital postoperative care beyond 30 days.Medication-related osteonecrosis of the jaw (MRONJ) is a challenging condition to treat. It has primarily been associated with anti-resorptive and anti-angiogenic drugs, which are increasingly being used to prevent adverse skeletally-related complications in patients with cancer and bone pathologies.&hellip;<span class="activity-read-more" id="activity-read-more-28460"><a href="http://www.nationalboardinstitute.com/activity/p/28460/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">209d29783fb220fa7f5c7a4a3ab219ac</guid>
				<title>Kenny became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28405/</link>
				<pubDate>Tue, 28 Jan 2025 11:18:05 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>